<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml producer="poppler" version="0.48.0">
<page number="1" position="absolute" top="0" left="0" height="1262" width="892">
	<fontspec id="0" size="10" family="Times" color="#231f20"/>
	<fontspec id="1" size="16" family="Times" color="#231f20"/>
	<fontspec id="2" size="14" family="Times" color="#231f20"/>
	<fontspec id="3" size="14" family="Times" color="#231f20"/>
	<fontspec id="4" size="13" family="Times" color="#231f20"/>
	<fontspec id="5" size="22" family="Times" color="#231f20"/>
	<fontspec id="6" size="25" family="Times" color="#231f20"/>
	<fontspec id="7" size="7" family="Times" color="#231f20"/>
	<fontspec id="8" size="14" family="Times" color="#231f20"/>
<text top="108" left="106" width="210" height="12" font="0">Archives of the Balkan Medical Union</text>
<text top="122" left="106" width="226" height="12" font="0">Copyright © 2019 Balkan Medical Union</text>
<text top="108" left="635" width="151" height="12" font="0">vol. 54, no. 2, pp. 334-338</text>
<text top="122" left="728" width="59" height="12" font="0">June 2019</text>
<text top="607" left="457" width="12" height="18" font="1">R</text>
<text top="611" left="469" width="43" height="13" font="0">ÉSUMÉ</text>
<text top="642" left="457" width="333" height="19" font="2"><b>La biopsie du ganglion sentinelle joue-t-elle un rôle </b></text>
<text top="661" left="457" width="229" height="19" font="2"><b>dans l’adénocarcinome du pancréas?</b></text>
<text top="698" left="457" width="333" height="19" font="3">L’adénocarcinome du pancréas reste l’une des tumeurs </text>
<text top="717" left="457" width="329" height="19" font="3">malignes les plus agressives au monde, malheureuse-</text>
<text top="736" left="457" width="333" height="19" font="3">ment associée à une survie à long terme très médiocre. </text>
<text top="754" left="457" width="329" height="19" font="3">Cependant, il semble que la seule option pour amé-</text>
<text top="773" left="457" width="335" height="19" font="3">liorer les résultats de ces patients reste la chirurgie </text>
<text top="792" left="457" width="329" height="19" font="3">radicale consistant en une résection en bloc de la tu-</text>
<text top="811" left="457" width="334" height="19" font="3">meur et des tissus environnants. En ce qui concerne </text>
<text top="829" left="457" width="329" height="19" font="3">l’étendue de la lymphadénectomie, un débat perma-</text>
<text top="848" left="457" width="334" height="19" font="3">nent persiste entre les pays de l’Est et de l’Ouest de </text>
<text top="867" left="457" width="334" height="19" font="3">l’Europe. Alors que les pays occidentaux considèrent </text>
<text top="886" left="457" width="333" height="19" font="3">qu’une dissection étendue des ganglions lymphatiques </text>
<text top="904" left="457" width="330" height="19" font="3">accroît la complication postopératoire, les pays orien-</text>
<text top="923" left="457" width="334" height="19" font="3">taux considèrent qu’il devrait s’agir du traitement de </text>
<text top="942" left="457" width="329" height="19" font="3">choix tant que ces tumeurs se disséminent habituelle-</text>
<text top="961" left="457" width="333" height="19" font="3">ment par voie lymphatique. Afin de déterminer quels </text>
<text top="980" left="457" width="329" height="19" font="3">patients pourraient bénéficier le plus après une dissec-</text>
<text top="998" left="457" width="334" height="19" font="3">tion étendue, certains auteurs ont proposé de réaliser </text>
<text top="1017" left="457" width="334" height="19" font="3">la technique de biopsie du ganglion sentinelle. Il s’agit </text>
<text top="1036" left="457" width="334" height="19" font="3">d’une revue de la littérature des plus grandes études </text>
<text top="1055" left="457" width="131" height="19" font="3">menées sur ce thème.</text>
<text top="607" left="106" width="12" height="18" font="1">A</text>
<text top="611" left="118" width="55" height="13" font="0">BSTRACT</text>
<text top="642" left="106" width="334" height="19" font="3">Pancreatic adenocarcinoma remains one of the most </text>
<text top="661" left="106" width="330" height="19" font="3">aggressive malignancies worldwide which is unfortu-</text>
<text top="679" left="106" width="333" height="19" font="3">nately associated with very poor long-term survival. </text>
<text top="698" left="106" width="329" height="19" font="3">However, it seems that the only option in order to im-</text>
<text top="717" left="106" width="334" height="19" font="3">prove the outcomes of these patients remains radical </text>
<text top="736" left="106" width="334" height="19" font="3">surgery consisting of in block resection of the tumor </text>
<text top="754" left="106" width="334" height="19" font="3">and the surrounding tissues. When it comes to the </text>
<text top="773" left="106" width="335" height="19" font="3">extent of the lymph node dissection, a permanent </text>
<text top="792" left="106" width="329" height="19" font="3">debate still exists between the eastern and the west-</text>
<text top="811" left="106" width="334" height="19" font="3">ern countries; while the Western countries consider </text>
<text top="829" left="106" width="333" height="19" font="3">that an extended lymph node dissection increases the </text>
<text top="848" left="106" width="334" height="19" font="3">postoperative complication worthwhile, the Eastern </text>
<text top="867" left="106" width="333" height="19" font="3">countries consider that this should be the treatment of </text>
<text top="886" left="106" width="334" height="19" font="3">choice as long as these tumors usually disseminate on </text>
<text top="904" left="106" width="333" height="19" font="3">the lymphatic route. In order to establish what patients </text>
<text top="923" left="106" width="329" height="19" font="3">could benefit most from an extended lymph node dis-</text>
<text top="942" left="106" width="329" height="19" font="3">section, certain authors proposed performing the sen-</text>
<text top="961" left="106" width="333" height="19" font="3">tinel lymph node biopsy technique. This is a literature </text>
<text top="980" left="106" width="329" height="19" font="3">review of the largest studies conducted on this theme.</text>
<text top="1021" left="106" width="73" height="16" font="4">Keywords: </text>
<text top="1017" left="182" width="254" height="19" font="3">sentinel node biopsy, pancreatic adenocar-</text>
<text top="1036" left="106" width="203" height="19" font="3">cinoma, lymph node metastases.  </text>
<text top="200" left="703" width="83" height="24" font="5">REVIEW</text>
<text top="311" left="106" width="535" height="27" font="6">DOES SENTINEL NODE BIOPSY PLAY A ROLE </text>
<text top="341" left="106" width="442" height="27" font="6">IN PANCREATIC ADENOCARCINOMA?</text>
<text top="393" left="106" width="153" height="17" font="3">       Nicolae BACALBASA</text>
<text top="392" left="259" width="27" height="10" font="7">1,2,3 </text>
<text top="393" left="294" width="119" height="17" font="3">, Irina BALESCU</text>
<text top="392" left="413" width="6" height="10" font="7">4</text>
<text top="393" left="419" width="143" height="17" font="3">, Cristian BALALAU</text>
<text top="392" left="563" width="15" height="10" font="7">2,5</text>
<text top="393" left="578" width="119" height="17" font="3">, Mihaela VILCU</text>
<text top="392" left="696" width="15" height="10" font="7">2,3</text>
<text top="393" left="711" width="10" height="17" font="3">, </text>
<text top="411" left="106" width="119" height="17" font="3">Iulian BREZEAN</text>
<text top="411" left="225" width="15" height="10" font="7">2,3</text>
<text top="436" left="106" width="5" height="11" font="7">1</text>
<text top="435" left="111" width="625" height="19" font="3"> Center of Excellence in Translational Medicine, Fundeni Clinical Institute, Bucharest, Romania</text>
<text top="455" left="106" width="5" height="11" font="7">2</text>
<text top="454" left="111" width="486" height="19" font="3"> „Carol Davila“ University of Medicine and Pharmacy, Bucharest, Romania</text>
<text top="473" left="106" width="5" height="11" font="7">3</text>
<text top="473" left="111" width="379" height="19" font="3"> „Ion Cantacuzino“ Clinical Hospital, Bucharest, Romania</text>
<text top="492" left="106" width="5" height="11" font="7">4</text>
<text top="491" left="111" width="329" height="19" font="3"> Ponderas Academic Hospital, Bucharest, Romania</text>
<text top="511" left="106" width="5" height="11" font="7">5</text>
<text top="510" left="111" width="365" height="19" font="3"> „Sf. Pantelimon“ Clinical Hospital, Bucharest, Romania</text>
<text top="529" left="515" width="272" height="19" font="8"><i>Received 25 Mar 2019, Accepted 03 May 2019</i></text>
<text top="552" left="550" width="236" height="12" font="0">https://doi.org/10.31688/ABMU.2019.54.2.18</text>
<text top="1113" left="143" width="167" height="13" font="0"> Address for correspondence:  </text>
<text top="1113" left="348" width="108" height="13" font="0"> Nicolae BACALBASA</text>
<text top="1131" left="348" width="388" height="13" font="0">Carol Davila“ University of Medicine and Pharmacy, Bucharest, Romania</text>
<text top="1148" left="348" width="333" height="13" font="0">Email: nicolae_bacalbasa@yahoo.ro, Phone 0040723540426</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="1262" width="892">
	<fontspec id="9" size="11" family="Times" color="#231f20"/>
<text top="91" left="552" width="235" height="14" font="9">Archives of the Balkan Medical Union</text>
<text top="1182" left="660" width="42" height="14" font="9">June </text>
<text top="1182" left="693" width="94" height="14" font="9">2019 / 335</text>
<text top="202" left="106" width="5" height="18" font="1">I</text>
<text top="206" left="112" width="85" height="13" font="0">NTRODUCTION</text>
<text top="237" left="136" width="304" height="19" font="3">Pancreatic adenocarcinoma still represents one </text>
<text top="256" left="106" width="334" height="19" font="3">of the most fearful malignancies, being associated </text>
<text top="275" left="106" width="333" height="19" font="3">with an extremely poor survival rate. This aspect </text>
<text top="294" left="106" width="334" height="19" font="3">is explained through the fact that most patients are </text>
<text top="313" left="106" width="333" height="19" font="3">diagnosed in advanced stages of the disease, when </text>
<text top="332" left="106" width="334" height="19" font="3">local invasion and/or distant metastases are already </text>
<text top="350" left="106" width="47" height="19" font="3">present</text>
<text top="351" left="153" width="5" height="11" font="7">1</text>
<text top="350" left="158" width="283" height="19" font="3">. Unlike other malignancies, in which the </text>
<text top="369" left="106" width="329" height="19" font="3">incidence of advanced stage disease and the can-</text>
<text top="388" left="106" width="335" height="19" font="3">cer-related mortality reported a decreasing trend, </text>
<text top="407" left="106" width="333" height="19" font="3">in pancreatic cancer these parameters remain at an </text>
<text top="426" left="106" width="333" height="19" font="3">extremely  high  level,  irrespectively  to  the  type  of </text>
<text top="445" left="106" width="199" height="19" font="3">performed therapeutic strategy</text>
<text top="445" left="305" width="5" height="11" font="7">2</text>
<text top="445" left="310" width="126" height="19" font="3">. In such cases, sur-</text>
<text top="464" left="106" width="333" height="19" font="3">gery with curative intent is no longer feasible, so the </text>
<text top="482" left="106" width="329" height="19" font="3">patient remains a candidate only for palliative treat-</text>
<text top="501" left="106" width="333" height="19" font="3">ment. In the remaining cases, in which the disease is </text>
<text top="520" left="106" width="334" height="19" font="3">diagnosed in a less advanced stage of the disease, it </text>
<text top="539" left="106" width="333" height="19" font="3">seems that the nodal status has a very important role </text>
<text top="558" left="106" width="226" height="19" font="3">in regard of the long term outcomes</text>
<text top="558" left="332" width="11" height="11" font="7">3-7</text>
<text top="558" left="343" width="4" height="19" font="3">.</text>
<text top="598" left="106" width="11" height="18" font="1">P</text>
<text top="601" left="117" width="68" height="13" font="0">ANCREATIC</text>
<text top="598" left="185" width="5" height="18" font="1"> </text>
<text top="601" left="190" width="44" height="13" font="0">TUMOR</text>
<text top="598" left="234" width="5" height="18" font="1"> </text>
<text top="601" left="240" width="67" height="13" font="0">RESECTION</text>
<text top="598" left="307" width="5" height="18" font="1"> </text>
<text top="601" left="313" width="25" height="13" font="0">AND</text>
<text top="598" left="338" width="5" height="18" font="1"> </text>
<text top="601" left="344" width="41" height="13" font="0">LYMPH</text>
<text top="598" left="385" width="5" height="18" font="1"> </text>
<text top="601" left="390" width="33" height="13" font="0">NODE</text>
<text top="598" left="423" width="5" height="18" font="1"> </text>
<text top="620" left="106" width="72" height="13" font="0">DISSECTION</text>
<text top="617" left="178" width="5" height="18" font="1"> </text>
<text top="620" left="184" width="12" height="13" font="0">IN</text>
<text top="617" left="196" width="5" height="18" font="1"> </text>
<text top="620" left="202" width="75" height="13" font="0">PANCREATIC</text>
<text top="617" left="277" width="5" height="18" font="1"> </text>
<text top="620" left="283" width="115" height="13" font="0">ADENOCARCINOMA</text>
<text top="652" left="136" width="300" height="19" font="3">Depending on the location of the primary tu-</text>
<text top="671" left="106" width="333" height="19" font="3">mor, certain types of pancreatic resections have been </text>
<text top="689" left="106" width="329" height="19" font="3">proposed; therefore, for pancreatic head malignan-</text>
<text top="708" left="106" width="330" height="19" font="3">cies, the surgical procedure of choice remains pancre-</text>
<text top="727" left="106" width="334" height="19" font="3">atoduodenectomy, procedure performed for the first </text>
<text top="746" left="106" width="195" height="19" font="3">time by Allen Whipple in 1940</text>
<text top="747" left="302" width="5" height="11" font="7">8</text>
<text top="746" left="307" width="132" height="19" font="3">; during this surgical </text>
<text top="765" left="106" width="333" height="19" font="3">procedure, the pancreatic head is removed in block </text>
<text top="784" left="106" width="329" height="19" font="3">with the distal part of the common bile duct, duode-</text>
<text top="803" left="106" width="333" height="19" font="3">num, gallbladder, as well as with the peri-duodenal </text>
<text top="821" left="106" width="258" height="19" font="3">and peri-pancreatic lymph node stations</text>
<text top="822" left="365" width="12" height="11" font="7">8,9</text>
<text top="821" left="376" width="64" height="19" font="3">. In cases </text>
<text top="840" left="106" width="329" height="19" font="3">presenting central or distal pancreatic tumors, a va-</text>
<text top="859" left="106" width="334" height="19" font="3">riety of procedures, such as distal pancreatectomy, </text>
<text top="878" left="106" width="334" height="19" font="3">alone or in association with splenectomy or central </text>
<text top="897" left="106" width="235" height="19" font="3">pancreatectomy, have been proposed</text>
<text top="897" left="341" width="20" height="11" font="7">10-12</text>
<text top="897" left="362" width="78" height="19" font="3">. While the </text>
<text top="916" left="106" width="334" height="19" font="3">extent of the surgical procedures in terms of visceral </text>
<text top="934" left="106" width="333" height="19" font="3">resections has been widely accepted, the extent of the </text>
<text top="953" left="106" width="329" height="19" font="3">lymph node dissection has been considered as a per-</text>
<text top="972" left="106" width="330" height="19" font="3">manent subject of debate. This fact is mainly corre-</text>
<text top="991" left="106" width="330" height="19" font="3">lated with the high capacity of the pancreatic adeno-</text>
<text top="1010" left="106" width="333" height="19" font="3">carcinoma to spread via lymphatic route; therefore, it </text>
<text top="1029" left="106" width="334" height="19" font="3">has been demonstrated that lymph node metastases </text>
<text top="1048" left="106" width="334" height="19" font="3">develop early in the course of disease in pancreatic </text>
<text top="1066" left="106" width="329" height="19" font="3">adenocarcinomas and represent one of the most im-</text>
<text top="1085" left="106" width="333" height="19" font="3">portant prognostic factors for the long-term survival. </text>
<text top="1104" left="106" width="333" height="19" font="3">However, the extent of the lymph node dissection has </text>
<text top="1123" left="106" width="334" height="19" font="3">been permanently debated, different opinions being </text>
<text top="1142" left="106" width="333" height="19" font="3">reported so far; while the European countries sustain </text>
<text top="202" left="457" width="333" height="19" font="3">the idea that an extended lymph node dissection in </text>
<text top="221" left="457" width="329" height="19" font="3">pancreatic adenocarcinoma does not improve the sur-</text>
<text top="240" left="457" width="330" height="19" font="3">vival and, moreover, increases the postoperative mor-</text>
<text top="259" left="457" width="333" height="19" font="3">bidity rates, the Eastern countries consider that such </text>
<text top="277" left="457" width="333" height="19" font="3">a lymph node dissection is perfectly justified in order </text>
<text top="296" left="457" width="303" height="19" font="3">to increase the chances for an improved survival</text>
<text top="297" left="760" width="20" height="11" font="7">13-17</text>
<text top="296" left="780" width="4" height="19" font="3">.</text>
<text top="315" left="487" width="303" height="19" font="3">One of the most debated subjects when it comes </text>
<text top="334" left="457" width="334" height="19" font="3">to the extent of the lymph node dissection is related </text>
<text top="353" left="457" width="334" height="19" font="3">to the para-aortic lymph nodes; in order to find out </text>
<text top="371" left="457" width="334" height="19" font="3">which is the chance to have metastatic cells at this </text>
<text top="390" left="457" width="330" height="19" font="3">level in patients with hepato-biliary-pancreatic malig-</text>
<text top="409" left="457" width="329" height="19" font="3">nancies, Noji et al conducted a study on 62 such pa-</text>
<text top="428" left="457" width="333" height="19" font="3">tients, in whom they injected indocyanine green into </text>
<text top="446" left="457" width="299" height="19" font="3">the sub-serous membrane in the Calot’s triangle</text>
<text top="447" left="756" width="9" height="11" font="7">18</text>
<text top="447" left="765" width="25" height="19" font="3">. In </text>
<text top="465" left="457" width="333" height="19" font="3">order to study which is the most appropriate amount </text>
<text top="484" left="457" width="335" height="19" font="3">of substance to be injected, the authors randomly </text>
<text top="503" left="457" width="335" height="19" font="3">grouped the 62 cases in three groups: in the first </text>
<text top="522" left="457" width="334" height="19" font="3">group, 1 mg/mL of indocyanine green was injected, </text>
<text top="540" left="457" width="333" height="19" font="3">in the second group 2.5 mg/mL were injected, while </text>
<text top="559" left="457" width="334" height="19" font="3">in the third group 5 mg/mL were used; in all cases, </text>
<text top="578" left="457" width="334" height="19" font="3">the indocyanine green was diluted in saline solution </text>
<text top="597" left="457" width="334" height="19" font="3">of a final volume of 0.5 mL; the authors reported a </text>
<text top="616" left="457" width="334" height="19" font="3">rate of para-aortic node detection of 20% in cases </text>
<text top="634" left="457" width="334" height="19" font="3">in which 1 mg/mL was injected, 80% for cases in </text>
<text top="653" left="457" width="329" height="19" font="3">which 2.5 mg/mL were injected, and 100% respec-</text>
<text top="672" left="457" width="330" height="19" font="3">tively in cases in which a concentration of 5 mg/</text>
<text top="691" left="457" width="334" height="19" font="3">mL was used. The authors also demonstrated that </text>
<text top="710" left="457" width="333" height="19" font="3">the recommended interval of time between injection </text>
<text top="728" left="457" width="333" height="19" font="3">and performing of the Kocher maneuver should be </text>
<text top="747" left="457" width="329" height="19" font="3">of 10 minutes in order to maximize the rate of detec-</text>
<text top="766" left="457" width="334" height="19" font="3">tion of the para-aortic lymph nodes; however, due to </text>
<text top="785" left="457" width="333" height="19" font="3">the presence of extended adhesions at the level of the </text>
<text top="804" left="457" width="334" height="19" font="3">hepato-duodenal ligament, the procedure could not </text>
<text top="822" left="457" width="333" height="19" font="3">be performed in 20 cases. In the remaining 42 cases, </text>
<text top="841" left="457" width="334" height="19" font="3">in whom the identification of the para-aortic lymph </text>
<text top="860" left="457" width="329" height="19" font="3">nodes was successfully completed, the pancreatic ori-</text>
<text top="879" left="457" width="333" height="19" font="3">gin of the tumor was described in five cases. When it </text>
<text top="898" left="457" width="334" height="19" font="3">comes to the location of the sentinel nodes in these </text>
<text top="916" left="457" width="333" height="19" font="3">cases, the authors reported their location at the level </text>
<text top="935" left="457" width="333" height="19" font="3">of the posterior surface of the pancreatic head, as well </text>
<text top="954" left="457" width="334" height="19" font="3">as on the right border of the abdominal aorta and at </text>
<text top="973" left="457" width="334" height="19" font="3">the origin of the left renal vein, suggesting that in </text>
<text top="992" left="457" width="334" height="19" font="3">patients with hepato-biliary-pancreatic carcinomas, </text>
<text top="1010" left="457" width="335" height="19" font="3">injecting 5 mg/mL of indocyanine green solution </text>
<text top="1029" left="457" width="333" height="19" font="3">might be useful, in order to detect the presence of the </text>
<text top="1048" left="457" width="311" height="19" font="3">sentinel node at the level of the para-aortic region</text>
<text top="1049" left="768" width="9" height="11" font="7">18</text>
<text top="1048" left="777" width="4" height="19" font="3">.</text>
<text top="1088" left="457" width="11" height="18" font="1">S</text>
<text top="1092" left="468" width="49" height="13" font="0">ENTINEL</text>
<text top="1088" left="518" width="5" height="18" font="1"> </text>
<text top="1092" left="523" width="33" height="13" font="0">NODE</text>
<text top="1088" left="556" width="5" height="18" font="1"> </text>
<text top="1092" left="562" width="67" height="13" font="0">DETECTION</text>
<text top="1088" left="628" width="5" height="18" font="1"> </text>
<text top="1092" left="634" width="12" height="13" font="0">IN</text>
<text top="1088" left="646" width="5" height="18" font="1"> </text>
<text top="1092" left="652" width="75" height="13" font="0">PANCREATIC</text>
<text top="1088" left="727" width="5" height="18" font="1"> </text>
<text top="1092" left="733" width="49" height="13" font="0">CANCER</text>
<text top="1123" left="487" width="300" height="19" font="3">Although the anatomical study of the lym-</text>
<text top="1142" left="457" width="333" height="19" font="3">phatic system of the pancreas reported a significant </text>
<text top="130" left="457" width="76" height="16" font="4">Mots-clés: </text>
<text top="126" left="536" width="250" height="19" font="3">biopsie du ganglion sentinelle, adénocar-</text>
<text top="145" left="457" width="292" height="19" font="3">cinome du pancréas, métastases ganglionnaires.</text>
</page>
<page number="3" position="absolute" top="0" left="0" height="1262" width="892">
<text top="91" left="106" width="524" height="14" font="9">Does sentinel node biopsy play a role in pancreatic adenocarcinoma? – BACALBASA et al</text>
<text top="1182" left="106" width="143" height="14" font="9">336  /  vol. 54, no. 2</text>
<text top="126" left="106" width="330" height="19" font="3">development, it seems that the use of lymphatic map-</text>
<text top="145" left="106" width="329" height="19" font="3">ping in pancreatic adenocarcinoma still remains lim-</text>
<text top="164" left="106" width="330" height="19" font="3">ited. It has been stated the fact that lymphatic drain-</text>
<text top="183" left="106" width="333" height="19" font="3">age of the pancreas is a very complex one, presenting </text>
<text top="201" left="106" width="333" height="19" font="3">multiple lymphatic channels and different lymphatic </text>
<text top="220" left="106" width="333" height="19" font="3">routes, concentrating the lymphatic outflow in a high </text>
<text top="239" left="106" width="329" height="19" font="3">number of presumed sentinel nodes, which are main-</text>
<text top="258" left="106" width="334" height="19" font="3">ly located at the level of the retroperitoneal space; </text>
<text top="277" left="106" width="334" height="19" font="3">therefore, the analysis of these patterns of spread is </text>
<text top="295" left="106" width="84" height="19" font="3">very difficult</text>
<text top="296" left="190" width="9" height="11" font="7">19</text>
<text top="295" left="200" width="241" height="19" font="3">. Moreover, it seems that the use of </text>
<text top="314" left="106" width="334" height="19" font="3">the most representative imagistic methods, such as </text>
<text top="333" left="106" width="334" height="19" font="3">computed tomography, magnetic resonance or even </text>
<text top="352" left="106" width="335" height="19" font="3">positron emission tomography, are not reliable in </text>
<text top="371" left="106" width="334" height="19" font="3">order to offer precise information in regard to the </text>
<text top="389" left="106" width="330" height="19" font="3">lymphatic status in patients with pancreatic adeno-</text>
<text top="408" left="106" width="71" height="19" font="3">carcinomas</text>
<text top="409" left="177" width="21" height="11" font="7">20,21</text>
<text top="408" left="198" width="4" height="19" font="3">.</text>
<text top="427" left="136" width="304" height="19" font="3">In order to improve the methods of evaluation </text>
<text top="446" left="106" width="329" height="19" font="3">and detection of the possible lymph node involve-</text>
<text top="465" left="106" width="334" height="19" font="3">ment in pancreatic adenocarcinoma, certain authors </text>
<text top="483" left="106" width="283" height="19" font="3">proposed the use of the sentinel node biopsy.</text>
<text top="502" left="136" width="300" height="19" font="3">An interesting study which investigated the ef-</text>
<text top="521" left="106" width="334" height="19" font="3">ficacy of the method was conducted by Hirono et al </text>
<text top="540" left="106" width="163" height="19" font="3">and was published in 2012</text>
<text top="540" left="268" width="9" height="11" font="7">22</text>
<text top="540" left="278" width="162" height="19" font="3">. The authors investigated </text>
<text top="559" left="106" width="333" height="19" font="3">the main patterns of lymphatic spread in 20 patients </text>
<text top="577" left="106" width="333" height="19" font="3">with pancreatic head adenocarcinomas: in 10 cases, </text>
<text top="596" left="106" width="333" height="19" font="3">the authors injected the tracer in the anterior surface </text>
<text top="615" left="106" width="335" height="19" font="3">of the pancreatic head, while in the remaining 10 </text>
<text top="634" left="106" width="333" height="19" font="3">cases the tracer was injected in the posterior surface. </text>
<text top="653" left="106" width="333" height="19" font="3">The authors demonstrated that there are seven main </text>
<text top="671" left="106" width="335" height="19" font="3">lymphatic patterns of spread, the most commonly </text>
<text top="690" left="106" width="334" height="19" font="3">encountered being the one related to the para-aortic </text>
<text top="709" left="106" width="333" height="19" font="3">lymph nodes (in 85% cases) followed by the superior </text>
<text top="728" left="106" width="334" height="19" font="3">mesenteric artery (in 20% of cases). Moreover, the </text>
<text top="747" left="106" width="333" height="19" font="3">authors underlined the fact that the mean interval to </text>
<text top="765" left="106" width="334" height="19" font="3">reach the lymph nodes at the origin of the superior </text>
<text top="784" left="106" width="333" height="19" font="3">mesenteric artery was longer to those in para-aortic </text>
<text top="803" left="106" width="334" height="19" font="3">area, suggesting that the lymph node dissection at </text>
<text top="822" left="106" width="329" height="19" font="3">the level of the two areas might play a similar onco-</text>
<text top="841" left="106" width="68" height="19" font="3">logical role</text>
<text top="841" left="174" width="9" height="11" font="7">22</text>
<text top="841" left="183" width="256" height="19" font="3">. These data demonstrating the presence </text>
<text top="859" left="106" width="333" height="19" font="3">of seven main lymphatic routes came to demonstrate </text>
<text top="878" left="106" width="333" height="19" font="3">once again the complexity of the lymphatic drainage </text>
<text top="897" left="106" width="161" height="19" font="3">from the pancreatic head.</text>
<text top="916" left="136" width="305" height="19" font="3">When it comes to the utility of sentinel node </text>
<text top="935" left="106" width="329" height="19" font="3">detection in pancreatic body adenocarcinoma, pre-</text>
<text top="953" left="106" width="330" height="19" font="3">liminary results published by the Polish authors con-</text>
<text top="972" left="106" width="333" height="19" font="3">ducted by Durczynski do not seem very encouraging. </text>
<text top="991" left="106" width="334" height="19" font="3">The authors included in their study 13 patients with </text>
<text top="1010" left="106" width="334" height="19" font="3">locally advanced pancreatic body tumors submitted </text>
<text top="1029" left="106" width="334" height="19" font="3">to surgery at the Medical University of Lodz during </text>
<text top="1047" left="106" width="104" height="19" font="3">the year of 2010</text>
<text top="1048" left="210" width="9" height="11" font="7">23</text>
<text top="1047" left="220" width="221" height="19" font="3">; in all cases, 1 mL of patent blue </text>
<text top="1066" left="106" width="334" height="19" font="3">was injected in the center of the pancreatic tumor </text>
<text top="1085" left="106" width="334" height="19" font="3">just after opening the lesser sac. Five minutes later, </text>
<text top="1104" left="106" width="334" height="19" font="3">the colored lymphatic nodes were retrieved and sent </text>
<text top="1123" left="106" width="335" height="19" font="3">to the histopathological studies. After performing </text>
<text top="1141" left="106" width="334" height="19" font="3">this protocol, the detection rate of the presumptive </text>
<text top="126" left="457" width="333" height="19" font="3">sentinel node was of only 38.4%, most commonly </text>
<text top="145" left="457" width="334" height="19" font="3">the sentinel node being located at the level of the </text>
<text top="164" left="457" width="334" height="19" font="3">proximal area of the splenic artery (11p lymph node </text>
<text top="183" left="457" width="329" height="19" font="3">station). However, the results of the study are discour-</text>
<text top="201" left="457" width="334" height="19" font="3">aging, all the sentinel nodes as well as the retrieved </text>
<text top="220" left="457" width="236" height="19" font="3">non-sentinel nodes being metastatic</text>
<text top="221" left="693" width="9" height="11" font="7">22</text>
<text top="220" left="702" width="89" height="19" font="3">. This aspect </text>
<text top="239" left="457" width="334" height="19" font="3">might be explained through the fact that most cases </text>
<text top="258" left="457" width="334" height="19" font="3">presented large tumoral masses which are thought </text>
<text top="277" left="457" width="334" height="19" font="3">to invade and block the lymphatic structures in the </text>
<text top="295" left="457" width="330" height="19" font="3">close proximity, as well as by the fact that the trac-</text>
<text top="314" left="457" width="333" height="19" font="3">er was injected directly in the center of the tumor. </text>
<text top="333" left="457" width="334" height="19" font="3">Another explanation given by the authors for these </text>
<text top="352" left="457" width="334" height="19" font="3">results is related to the learning curve; the authors </text>
<text top="371" left="457" width="333" height="19" font="3">underlined the fact that in breast cancer surgery, the </text>
<text top="389" left="457" width="334" height="19" font="3">learning curve for sentinel lymph node dissection is </text>
<text top="408" left="457" width="333" height="19" font="3">longer than 20 cases, while in pancreatic cancer this </text>
<text top="427" left="457" width="333" height="19" font="3">curve is hard to be surpassed due to the low number </text>
<text top="446" left="457" width="241" height="19" font="3">of cases diagnosed with this pathology</text>
<text top="446" left="697" width="21" height="11" font="7">23,24</text>
<text top="446" left="718" width="4" height="19" font="3">.</text>
<text top="465" left="487" width="306" height="19" font="3">More promising results in terms of sentinel </text>
<text top="483" left="457" width="333" height="19" font="3">lymph node dissection in pancreatic tumors came </text>
<text top="502" left="457" width="334" height="19" font="3">from Spain; this time the authors only referred to </text>
<text top="521" left="457" width="335" height="19" font="3">pancreatic head adenocarcinoma and included in </text>
<text top="540" left="457" width="334" height="19" font="3">their study seven such patients with presumed early </text>
<text top="559" left="457" width="334" height="19" font="3">stages of the disease. In all cases the mapping was </text>
<text top="577" left="457" width="333" height="19" font="3">performed after Technetium injection one day before </text>
<text top="596" left="457" width="334" height="19" font="3">surgery via endoscopic ultrasonography. At the time </text>
<text top="615" left="457" width="329" height="19" font="3">of surgery, resection with curative intent was per-</text>
<text top="634" left="457" width="334" height="19" font="3">formed in four cases, while the sentinel nodes were </text>
<text top="653" left="457" width="329" height="19" font="3">identified in two cases, in both cases the nodes be-</text>
<text top="671" left="457" width="334" height="19" font="3">ing found at the level of the inter-aorto-cava region. </text>
<text top="690" left="457" width="330" height="19" font="3">However, the final histopathological studies demon-</text>
<text top="709" left="457" width="333" height="19" font="3">strate the presence of lymph node metastases into a </text>
<text top="728" left="457" width="124" height="19" font="3">single sentinel node</text>
<text top="728" left="581" width="9" height="11" font="7">25</text>
<text top="728" left="590" width="4" height="19" font="3">.</text>
<text top="747" left="487" width="304" height="19" font="3">Another interesting study which focused on the </text>
<text top="765" left="457" width="329" height="19" font="3">role of sentinel node biopsy in pancreatic head adeno-</text>
<text top="784" left="457" width="330" height="19" font="3">carcinoma came from the Japanese authors conduct-</text>
<text top="803" left="457" width="334" height="19" font="3">ed by Ohta et al; the authors initially demonstrated </text>
<text top="822" left="457" width="333" height="19" font="3">that number 13 (posterior pancreatic-duodenal lymph </text>
<text top="841" left="457" width="334" height="19" font="3">node group) represent a major regional drainage site </text>
<text top="859" left="457" width="329" height="19" font="3">of the pancreatic head, the status of this nodes pre-</text>
<text top="878" left="457" width="333" height="19" font="3">dicting that of the number 16 (abdominal para-aortic </text>
<text top="897" left="457" width="125" height="19" font="3">lymph node group)</text>
<text top="898" left="582" width="9" height="11" font="7">26</text>
<text top="897" left="591" width="195" height="19" font="3">. In the current study, the au-</text>
<text top="916" left="457" width="333" height="19" font="3">thors injected 2% patent blue dye in the peritumoral </text>
<text top="935" left="457" width="335" height="19" font="3">area, and 5 minutes later, the blue stained nodes </text>
<text top="953" left="457" width="333" height="19" font="3">within the area of the no. 13 lymph node group were </text>
<text top="972" left="457" width="334" height="19" font="3">identified, excised and sent for the frozen section. </text>
<text top="991" left="457" width="333" height="19" font="3">The further surgical decision was based on the status </text>
<text top="1010" left="457" width="333" height="19" font="3">of these nodes and consisted of extended lymph node </text>
<text top="1029" left="457" width="334" height="19" font="3">dissection to number 16 lymph nodes if the sentinel </text>
<text top="1047" left="457" width="334" height="19" font="3">nodes were positive and ending the procedure if the </text>
<text top="1066" left="457" width="334" height="19" font="3">sentinel nodes at the level of the group number 13 </text>
<text top="1085" left="457" width="334" height="19" font="3">were negatives. The authors proposed this protocol </text>
<text top="1104" left="457" width="329" height="19" font="3">in 21 cases, nine of them being successfully submit-</text>
<text top="1123" left="457" width="329" height="19" font="3">ted to this approach; among the nine cases, success-</text>
<text top="1141" left="457" width="334" height="19" font="3">ful detection of the sentinel node at the level of the </text>
</page>
<page number="4" position="absolute" top="0" left="0" height="1262" width="892">
	<fontspec id="10" size="11" family="Times" color="#231f20"/>
<text top="91" left="552" width="235" height="14" font="9">Archives of the Balkan Medical Union</text>
<text top="1182" left="661" width="42" height="14" font="9">June </text>
<text top="1182" left="693" width="93" height="14" font="9">2019 / 337</text>
<text top="126" left="106" width="334" height="19" font="3">station number 13 was found in eight cases. Among </text>
<text top="145" left="106" width="330" height="19" font="3">these cases, there were four cases with positive senti-</text>
<text top="163" left="106" width="333" height="19" font="3">nel nodes which were further submitted to extended </text>
<text top="182" left="106" width="334" height="19" font="3">lymph node dissection and four cases with negative </text>
<text top="201" left="106" width="334" height="19" font="3">sentinel nodes in which the surgical procedure was </text>
<text top="219" left="106" width="334" height="19" font="3">ended at this time. The overall 3-years survival rate </text>
<text top="238" left="106" width="333" height="19" font="3">for the entire group was 36%, three of the four cases </text>
<text top="257" left="106" width="334" height="19" font="3">with negative sentinel nodes being alive at the three </text>
<text top="275" left="106" width="334" height="19" font="3">years follow-up. These data enabled the authors to </text>
<text top="294" left="106" width="329" height="19" font="3">declare that detecting the sentinel node in pancre-</text>
<text top="313" left="106" width="334" height="19" font="3">atic head adenocarcinoma might provide an efficient </text>
<text top="331" left="106" width="334" height="19" font="3">identification of the patients at high risk, and might </text>
<text top="350" left="106" width="329" height="19" font="3">impede the surgeon to perform an unnecessary ex-</text>
<text top="369" left="106" width="189" height="19" font="3">tended lymph node dissection</text>
<text top="369" left="295" width="9" height="11" font="7">27</text>
<text top="369" left="304" width="4" height="19" font="3">.</text>
<text top="408" left="106" width="12" height="18" font="1">C</text>
<text top="412" left="118" width="77" height="13" font="0">ONCLUSIONS</text>
<text top="443" left="136" width="300" height="19" font="3">Data reported so far in cases with pancreatic ad-</text>
<text top="462" left="106" width="334" height="19" font="3">enocarcinomas are inconstant when it comes to the </text>
<text top="481" left="106" width="333" height="19" font="3">role of sentinel lymph node detection. This aspect </text>
<text top="499" left="106" width="333" height="19" font="3">is mainly related to the fact that most patients are </text>
<text top="518" left="106" width="333" height="19" font="3">diagnosed in advanced stages of the disease when the </text>
<text top="537" left="106" width="334" height="19" font="3">main lymphatic ducts are already obstructed by the </text>
<text top="555" left="106" width="333" height="19" font="3">tumoral involvement. Moreover, due to the relatively </text>
<text top="574" left="106" width="329" height="19" font="3">low number of cases in which resection with cura-</text>
<text top="593" left="106" width="329" height="19" font="3">tive intent is feasible, the learning curve is very dif-</text>
<text top="611" left="106" width="333" height="19" font="3">ficult to be surpassed. It seems that the best results in </text>
<text top="630" left="106" width="334" height="19" font="3">terms of sentinel lymph node detection are reported </text>
<text top="649" left="106" width="334" height="19" font="3">in cases presenting lower tumoral volumes as well as </text>
<text top="667" left="106" width="334" height="19" font="3">in those cases in which the tracer is injected in the </text>
<text top="686" left="106" width="333" height="19" font="3">peritumoral area and not directly in the center of the </text>
<text top="704" left="106" width="334" height="19" font="3">tumor. However, further studies are still needed in </text>
<text top="723" left="106" width="180" height="19" font="3">order to validate the method</text>
<text top="784" left="106" width="267" height="15" font="4">Compliance with Ethics Requirements:</text>
<text top="798" left="136" width="304" height="19" font="8"><i>„The authors declare no conflict of interest regarding </i></text>
<text top="816" left="106" width="65" height="19" font="8"><i>this article“</i></text>
<text top="875" left="106" width="12" height="18" font="1">R</text>
<text top="879" left="118" width="71" height="13" font="0">EFERENCES</text>
<text top="910" left="106" width="333" height="15" font="9">1.  Diaconu C, Mateescu D, Balaceanu A, Marcu M, Jianu V, </text>
<text top="925" left="128" width="311" height="15" font="9">Stanica A. Pancreatic cancer presenting with paraneoplastic </text>
<text top="941" left="128" width="312" height="15" font="9">thrombophlebitis: a case report. <i>Journal of Medicine and Life </i></text>
<text top="957" left="128" width="86" height="15" font="9">2010;3(1): 96-99.</text>
<text top="972" left="106" width="333" height="15" font="9">2.  Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. <i>CA </i></text>
<text top="988" left="128" width="158" height="15" font="10"><i>Cancer J Clin.</i> 2015; 65(1):5-29.</text>
<text top="1004" left="106" width="330" height="15" font="9">3.  Katz MH, Hwang R, Fleming JB, Evans DB. Tumor-node-</text>
<text top="1019" left="128" width="311" height="15" font="9">metastasis staging of pancreatic adenocarcinoma. <i>CA Cancer </i></text>
<text top="1035" left="128" width="136" height="15" font="10"><i>J Clin.</i> 2008;58(2):111-125.</text>
<text top="1051" left="106" width="329" height="15" font="9">4.  DiMagno EP, Reber HA, Tempero MA. AGA technical re-</text>
<text top="1066" left="128" width="308" height="15" font="9">view on the epidemiology, diagnosis, and treatment of pancre-</text>
<text top="1082" left="128" width="312" height="15" font="9">atic ductal adenocarcinoma. American Gastro enterological </text>
<text top="1098" left="128" width="265" height="15" font="9">Association. <i>Gastroenterology.</i> 1999;117(6):1464-1484.</text>
<text top="1113" left="106" width="333" height="15" font="9">5.  Kedra B, Popiela T, Sierzega M, Precht A. Prognostic factors </text>
<text top="1129" left="128" width="308" height="15" font="9">of long-term survival after resective procedures for pancre-</text>
<text top="1144" left="128" width="296" height="15" font="9">atic cancer. <i>Hepatogastroenterology</i> 2001; 48(42):1762-1766.</text>
<text top="126" left="457" width="330" height="15" font="9">6.  Nathanson SD, Shah R, Rosso K. Sentinel lymph node me-</text>
<text top="142" left="478" width="311" height="15" font="9">tastases in cancer: causes, detection and their role in disease </text>
<text top="158" left="478" width="254" height="15" font="9">progression. <i>Semin Cell Dev Biol</i> 2015;38:106-116.</text>
<text top="175" left="457" width="334" height="15" font="9">7.  Stacker SA, Williams SP, Karnezis T, Shayan R, Fox SB, </text>
<text top="191" left="478" width="308" height="15" font="9">Achen MG. Lymphangiogenesis and lymphatic vessel remod-</text>
<text top="207" left="478" width="268" height="15" font="9">elling in cancer. <i>Nat Rev Cancer.</i> 2014;14(3):159-172.</text>
<text top="223" left="457" width="330" height="15" font="9">8.  Whipple AO. The rationale of radical surgery for can-</text>
<text top="239" left="478" width="311" height="15" font="9">cer of the pancreas and ampullary region. <i>Ann Surg.</i> </text>
<text top="255" left="478" width="106" height="15" font="9">1941;114(4):612-615.</text>
<text top="272" left="457" width="333" height="15" font="9">9.  Bhatti I, Peacock O, Awan AK, Semeraro D, Larvin M, Hall </text>
<text top="288" left="478" width="313" height="15" font="9">RI. Lymph node ratio versus number of affected lymph </text>
<text top="304" left="478" width="308" height="15" font="9">nodes as predictors of survival for resected pancreatic ad-</text>
<text top="320" left="478" width="250" height="15" font="9">enocarcinoma. <i>World J Surg.</i> 2010; 34(4):768-775.</text>
<text top="336" left="457" width="333" height="15" font="9">10.  Doi  R,  Kami  K,  Ito  D,  et  al.  Prognostic  implication  of </text>
<text top="352" left="478" width="312" height="15" font="9">para-aortic lymph node metastasis in resectable pancreatic </text>
<text top="369" left="478" width="208" height="15" font="9">cancer. <i>World J Surg.</i> 2007; 31(1):147-154.</text>
<text top="385" left="457" width="329" height="15" font="9">11.  Murakami Y, Uemura K, Sudo T, et al. Number of metastat-</text>
<text top="401" left="478" width="311" height="15" font="9">ic lymph nodes, but not lymph node ratio, is an independent </text>
<text top="417" left="478" width="311" height="15" font="9">prognostic factor after resection of pancreatic carcinoma. <i>J </i></text>
<text top="433" left="478" width="181" height="15" font="10"><i>Am Coll Surg.</i> 2010; 211(2):196-204.</text>
<text top="449" left="457" width="330" height="15" font="9">12.  Kobayashi K, Sadakari Y, Ohtsuka T, et al. Factors in in-</text>
<text top="466" left="478" width="313" height="15" font="9">traductal papillary mucinous neoplasms of the pancreas </text>
<text top="482" left="478" width="312" height="15" font="9">predictive of lymph node metastasis. <i>Pancreatology.</i> 2010; </text>
<text top="498" left="478" width="73" height="15" font="9">10(6):720-725.</text>
<text top="514" left="457" width="329" height="15" font="9">13.  Masui T, Kubota T, Aoki K, et al. Long-term survival af-</text>
<text top="530" left="478" width="313" height="15" font="9">ter resection of pancreatic ductal adenocarcinoma with </text>
<text top="546" left="478" width="312" height="15" font="9">para-aortic lymph node metastasis: case report. <i>World J Surg </i></text>
<text top="563" left="478" width="113" height="15" font="10"><i>Oncol. </i>2013;11(1):195.</text>
<text top="579" left="457" width="333" height="15" font="9">14.  Peparini N. Mesopancreas: a boundless structure, namely </text>
<text top="595" left="478" width="308" height="15" font="9">the rationale for dissection of the paraaortic area in pancrea-</text>
<text top="611" left="478" width="313" height="15" font="9">ticoduodenectomy for pancreatic head carcinoma. <i>World J </i></text>
<text top="627" left="478" width="194" height="15" font="10"><i>Gastroenterol.</i> 2015; 21(10):2865-2870.</text>
<text top="643" left="457" width="329" height="15" font="9">15. Tol JA, Gouma DJ, Bassi C, et al. Definition of a stand-</text>
<text top="660" left="478" width="308" height="15" font="9">ard lymphadenectomy in surgery for pancreatic ductal ad-</text>
<text top="676" left="478" width="312" height="15" font="9">enocarcinoma: a consensus statement by the International </text>
<text top="692" left="478" width="312" height="15" font="9">Study Group on Pancreatic Surgery (ISGPS). <i>Surgery.</i> 2014; </text>
<text top="708" left="478" width="81" height="15" font="9">156(3):591-600.</text>
<text top="724" left="457" width="333" height="15" font="9">16.  Svoronos  C,  Tsoulfas  G,  Katsourakis  A,  Noussios  G, </text>
<text top="740" left="478" width="308" height="15" font="9">Chatzitheoklitos E, Marakis NG. Role of extended lym-</text>
<text top="757" left="478" width="308" height="15" font="9">phadenectomy in the treatment of pancreatic head ad-</text>
<text top="773" left="478" width="311" height="15" font="9">enocarcinoma: review and meta-analysis. <i>ANZ J Surg.</i> </text>
<text top="789" left="478" width="107" height="15" font="9">2014;84(10):706-711.</text>
<text top="805" left="457" width="329" height="15" font="9">17.  Ke K, Chen W, Chen Y. Standard and extended lymphad-</text>
<text top="821" left="478" width="313" height="15" font="9">enectomy for adenocarcinoma of the pancreatic head: a </text>
<text top="837" left="478" width="312" height="15" font="9">meta-analysis and systematic review. <i>J Gastroenterol Hepatol. </i></text>
<text top="853" left="478" width="102" height="15" font="9">2014;29(3):453-462.</text>
<text top="870" left="457" width="330" height="15" font="9">18.  Noji T, Narasaki H, Ebihara Y, et al. Near infrared fluores-</text>
<text top="886" left="478" width="312" height="15" font="9">cence light imaging for lymphatic flow toward para-aortic </text>
<text top="902" left="478" width="308" height="15" font="9">lymph node from the Calot’s triangle: a prospective explora-</text>
<text top="918" left="478" width="293" height="15" font="9">tory study. <i>Photodiagnosis Photodyn Ther.</i> 2018;24:274-279.</text>
<text top="934" left="457" width="333" height="15" font="9">19.  Kitagawa H, Ohta T, Makino I H, et al. Carcinomas of the </text>
<text top="950" left="478" width="308" height="15" font="9">ventral and dorsal pancreas exhibit different patterns of lym-</text>
<text top="967" left="478" width="241" height="15" font="9">phatic spread. <i>Front Biosci</i> 2008; 13:2728-2735.</text>
<text top="983" left="457" width="332" height="15" font="9">20.  Roche CJ, Hughes ML, Garvey CJ, et al. CT and pathologic </text>
<text top="999" left="478" width="312" height="15" font="9">assessment of prospective nodal staging in patients with </text>
<text top="1015" left="478" width="311" height="15" font="9">ductal adenocarcinoma of the head of the pancreas. <i>AJR </i></text>
<text top="1031" left="478" width="199" height="15" font="10"><i>Am J Roentgenol. </i>2003; 180(2):475-480.</text>
<text top="1047" left="457" width="333" height="15" font="9">21.  Imai H, Doi R, Kanazawa H, et al. Preoperative assessment </text>
<text top="1064" left="478" width="308" height="15" font="9">of para-aortic lymph node metastasis in patients with pan-</text>
<text top="1080" left="478" width="267" height="15" font="9">creatic cancer. <i>Int J Clin Oncol.</i> 2010; 15(3):294-300.</text>
<text top="1096" left="457" width="329" height="15" font="9">22.  Hirono S, Tani M, Kawai M, et al. Identification of the lym-</text>
<text top="1112" left="478" width="311" height="15" font="9">phatic drainage pathways from the pancreatic head guided </text>
<text top="1128" left="478" width="308" height="15" font="9">by indocyanine green fluorescence imaging during pancrea-</text>
<text top="1144" left="478" width="253" height="15" font="9">ticoduodenectomy. <i>Dig Surg.</i> 2012; 29(2):132-139.</text>
</page>
<page number="5" position="absolute" top="0" left="0" height="1262" width="892">
<text top="91" left="106" width="524" height="14" font="9">Does sentinel node biopsy play a role in pancreatic adenocarcinoma? – BACALBASA et al</text>
<text top="1182" left="106" width="143" height="14" font="9">338  /  vol. 54, no. 2</text>
<text top="126" left="106" width="335" height="15" font="9">23. Durczynski A, Hogendorf P, Szymanski D, Grzelak P, </text>
<text top="142" left="128" width="311" height="15" font="9">Strzelczyk J. Sentinel lymph node mapping in tumors of the </text>
<text top="158" left="128" width="312" height="15" font="9">pancreatic body: preliminary report. <i>Contemp Oncol</i> (Pozn). </text>
<text top="173" left="128" width="106" height="15" font="9">2012; 16(3):206-209.</text>
<text top="189" left="106" width="333" height="15" font="9">24.  Hutchinson JR, Chagpar AB, Scoggins CR, et al. Surgeon </text>
<text top="205" left="128" width="313" height="15" font="9">and community factors affecting breast cancer sentinel </text>
<text top="221" left="128" width="270" height="15" font="9">lymph node biopsy. <i>Am J Surg.</i> 2005;190(6):903-906.</text>
<text top="126" left="457" width="333" height="15" font="9">25.  Beisani M, Roca I, Cardenas R, et al. Initial experience in </text>
<text top="142" left="478" width="311" height="15" font="9">sentinel lymph node detection in pancreatic cancer. <i>Rev Esp </i></text>
<text top="158" left="478" width="215" height="15" font="10"><i>Med Nucl Imagen Mol.</i> 2016;35(5):287-291.</text>
<text top="173" left="457" width="329" height="15" font="9">26.  Kayahara M, Nagakawa T, Ohta T, et al. Analysis of paraaor-</text>
<text top="189" left="478" width="308" height="15" font="9">tic lymph node involvement in pancreatic carcinoma: a sig-</text>
<text top="205" left="478" width="308" height="15" font="9">nificant indication for surgery? <i>Cancer. </i>1999; 85(3):583-590.</text>
<text top="221" left="457" width="333" height="15" font="9">27.  Ohta T, Kitagawa H, Kayahara M, et al. Sentinel lymph node </text>
<text top="236" left="478" width="311" height="15" font="9">navigation surgery for pancreatic head cancers. <i>Oncol Rep.</i> </text>
<text top="252" left="478" width="104" height="15" font="9">2003; 10(2):315-319.</text>
</page>
</pdf2xml>
